Phospho-MEK1/2 and uPAR Expression Determine Sensitivity of AML Blasts to a Urokinase-Activated Anthrax Lethal Toxin (PrAgU2/LF)()

In this study, we attempt to target both the urokinase plasminogen activator and the mitogen-activated protein kinase pathway in acute myeloid leukemia (AML) cell lines and primary AML blasts using PrAgU2/LF, a urokinase-activated anthrax lethal toxin. PrAgU2/LF was cytotoxic to five out of nine AML...

Descripción completa

Detalles Bibliográficos
Autores principales: Bekdash, Amira, Darwish, Manal, Timsah, Zahra, Kassab, Elias, Ghanem, Hadi, Najjar, Vicky, Ghosn, Marwan, Nasser, Selim, El-Hajj, Hiba, Bazerbachi, Ali, Liu, Shihui, Leppla, Stephen H., Frankel, Arthur E., Abi-Habib, Ralph J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630967/
https://www.ncbi.nlm.nih.gov/pubmed/26500025
http://dx.doi.org/10.1016/j.tranon.2015.07.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630967/
https://www.ncbi.nlm.nih.gov/pubmed/26500025
http://dx.doi.org/10.1016/j.tranon.2015.07.001

Ejemplares similares